Senti Biosciences (SNTI) Competitors $2.81 -0.21 (-6.95%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$3.06 +0.26 (+9.07%) As of 09:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNTI vs. AURA, TRDA, TKNO, OLMA, CMPX, PHAT, RCKT, HRTX, ACB, and TERNShould you be buying Senti Biosciences stock or one of its competitors? The main competitors of Senti Biosciences include Aura Biosciences (AURA), Entrada Therapeutics (TRDA), Alpha Teknova (TKNO), Olema Pharmaceuticals (OLMA), Compass Therapeutics (CMPX), Phathom Pharmaceuticals (PHAT), Rocket Pharmaceuticals (RCKT), Heron Therapeutics (HRTX), Aurora Cannabis (ACB), and Terns Pharmaceuticals (TERN). These companies are all part of the "pharmaceutical products" industry. Senti Biosciences vs. Its Competitors Aura Biosciences Entrada Therapeutics Alpha Teknova Olema Pharmaceuticals Compass Therapeutics Phathom Pharmaceuticals Rocket Pharmaceuticals Heron Therapeutics Aurora Cannabis Terns Pharmaceuticals Senti Biosciences (NASDAQ:SNTI) and Aura Biosciences (NASDAQ:AURA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation, community ranking and profitability. Do institutionals and insiders hold more shares of SNTI or AURA? 25.7% of Senti Biosciences shares are owned by institutional investors. Comparatively, 96.8% of Aura Biosciences shares are owned by institutional investors. 3.1% of Senti Biosciences shares are owned by insiders. Comparatively, 5.4% of Aura Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility and risk, SNTI or AURA? Senti Biosciences has a beta of 2.23, meaning that its share price is 123% more volatile than the S&P 500. Comparatively, Aura Biosciences has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500. Do analysts prefer SNTI or AURA? Senti Biosciences presently has a consensus price target of $8.50, suggesting a potential upside of 202.49%. Aura Biosciences has a consensus price target of $22.00, suggesting a potential upside of 231.83%. Given Aura Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Aura Biosciences is more favorable than Senti Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Senti Biosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Aura Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 Is SNTI or AURA more profitable? Aura Biosciences' return on equity of -41.57% beat Senti Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Senti BiosciencesN/A -154.84% -77.42% Aura Biosciences N/A -41.57%-36.43% Does the media prefer SNTI or AURA? In the previous week, Senti Biosciences had 10 more articles in the media than Aura Biosciences. MarketBeat recorded 11 mentions for Senti Biosciences and 1 mentions for Aura Biosciences. Aura Biosciences' average media sentiment score of 1.87 beat Senti Biosciences' score of 0.35 indicating that Aura Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Senti Biosciences Neutral Aura Biosciences Very Positive Does the MarketBeat Community favor SNTI or AURA? Aura Biosciences received 21 more outperform votes than Senti Biosciences when rated by MarketBeat users. Likewise, 63.64% of users gave Aura Biosciences an outperform vote while only 53.85% of users gave Senti Biosciences an outperform vote. CompanyUnderperformOutperformSenti BiosciencesOutperform Votes753.85% Underperform Votes646.15% Aura BiosciencesOutperform Votes2863.64% Underperform Votes1636.36% Which has stronger valuation and earnings, SNTI or AURA? Senti Biosciences has higher revenue and earnings than Aura Biosciences. Aura Biosciences is trading at a lower price-to-earnings ratio than Senti Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSenti Biosciences$2.56M28.63-$71.06M-$10.84-0.26Aura BiosciencesN/AN/A-$76.41M-$1.90-3.49 SummaryAura Biosciences beats Senti Biosciences on 12 of the 17 factors compared between the two stocks. Get Senti Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SNTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNTI vs. The Competition Export to ExcelMetricSenti BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$73.29M$3.09B$5.57B$8.62BDividend YieldN/A1.58%5.28%4.18%P/E Ratio-0.1833.3227.1420.06Price / Sales28.63469.84419.32157.08Price / CashN/A168.6838.2534.64Price / Book0.193.457.064.70Net Income-$71.06M-$72.35M$3.23B$247.88M7 Day Performance-21.07%6.23%2.83%2.63%1 Month Performance-13.80%16.53%9.02%6.36%1 Year Performance4.04%-16.90%31.36%14.05% Senti Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNTISenti Biosciences2.3891 of 5 stars$2.81-7.0%$8.50+202.5%-2.7%$73.29M$2.56M-0.184Gap UpAURAAura Biosciences2.5596 of 5 stars$6.16+5.1%$22.00+257.1%-7.1%$309.66MN/A-3.5650Positive NewsTRDAEntrada Therapeutics2.9241 of 5 stars$8.14+7.1%$25.67+215.3%-49.3%$308.94M$172.22M5.12110Positive NewsTKNOAlpha Teknova2.8142 of 5 stars$5.73-0.7%$8.50+48.3%+233.5%$306.22M$38.25M-7.74240Positive NewsOLMAOlema Pharmaceuticals2.0994 of 5 stars$4.38-17.0%$24.50+459.4%-70.0%$299.68MN/A-2.0070CMPXCompass Therapeutics3.722 of 5 stars$2.15+2.4%$13.13+510.5%+99.2%$297.31M$850K-5.8120Positive NewsPHATPhathom Pharmaceuticals4.0871 of 5 stars$4.64+9.2%$17.60+279.3%-18.0%$296.71M$81.86M-0.82110Analyst ForecastOptions VolumeRCKTRocket Pharmaceuticals4.9577 of 5 stars$2.77+10.4%$21.21+665.9%-86.8%$295.80MN/A-1.01240Trending NewsAnalyst RevisionHigh Trading VolumeHRTXHeron Therapeutics3.935 of 5 stars$1.93+2.7%$5.50+185.0%-43.4%$294.45M$148.52M-10.72300News CoverageAnalyst ForecastAnalyst RevisionACBAurora Cannabis0.5448 of 5 stars$5.21-1.7%N/A+2.4%$292.88M$320.81M104.221,340Upcoming EarningsTERNTerns Pharmaceuticals4.1754 of 5 stars$3.28+5.5%$15.63+376.4%-44.1%$286.47MN/A-2.7840Positive News Related Companies and Tools Related Companies Aura Biosciences Alternatives Entrada Therapeutics Alternatives Alpha Teknova Alternatives Olema Pharmaceuticals Alternatives Compass Therapeutics Alternatives Phathom Pharmaceuticals Alternatives Rocket Pharmaceuticals Alternatives Heron Therapeutics Alternatives Aurora Cannabis Alternatives Terns Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNTI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNTI Stock Free SNTI Stock Alerts